2018 PET/CT Imaging – A Video CME Teaching Activity

• Apply state-of-the-art protocols to evaluate neurodegenerative disease and head and neck cancers to clinical practice.
• Optimize PET and PET-CT imaging protocols for the detection and follow up lung and breast cancer.
• Describe the advantages and pitfalls of PET and PET/CT.
• Differentiate normal variants and urgent findings on PET/CT.
• Discuss the utility of PET/CT when used to evaluate cardiac disease and gastrointestinal, thyroid and prostate cancers.

Session 1

PET/CT Techniques and Reporting Principles
Eric M. Rohren, M.D., Ph.D.

Evaluation of Neurodegenerative Diseases and Seizures
Jonathan McConathy, M.D., Ph.D.

PET/CT in Cardiology
Thomas H. Schindler, M.D.

Session 2

PET/CT in Lymphomas
Mark Tulchinsky, M.D., FACNM

PET/CT in Head and Neck Cancer
Don C. Yoo, M.D.

PET/CT in Malignancy of the Breast and Female Pelvis
Charito Love, M.D.

Session 3

PET/CT in Prostate Cancer
Jonathan McConathy, M.D., Ph.D.

PET/CT in Gastrointestinal Malignancies
Eric M. Rohren, M.D., Ph.D.

PET/CT in Cancers of the Skin
Mark Tulchinsky, M.D., FACNM

Session 4

Qualitative and Quantitative Response Criteria
Eric M. Rohren, M.D., Ph.D.

PET/CT in Infection and Inflammation Imaging
Don C. Yoo, M.D.

PET/CT in Malignancy of the Lung
Don C. Yoo, M.D.

Session 5

PET/CT in Metastatic Skeletal Disease and Primary Tumors
Charito Love, M.D.

PET/CT in Thyroid Cancer
Mark Tulchinsky, M.D., FACNM

Session 6

Growing PET/CT Referrals
Eric M. Rohren, M.D., Ph.D.

Ga-68 and Lu-177 DOTATATE in Neuroendocrine Tumors
Charito Love, M.D.